Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women

Rossella E. Nappi *Research Center for Reproductive Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, ItalyCorrespondence[email protected]

Anna Maria PaolettiDepartment of Obstetrics and Gynecology, University of Cagliari, Cagliari, Italy

Annibale VolpeUniversity of Modena, Modena, Italy

Luca ChiovatoDepartment of Internal Medicine and Endocrinology, IRCCS Maugeri Foundation, University of Pavia, Italy

Brandon HowardTeva Global Medical Affairs, Frazer, PA, USA

Herman Weiss ˆTeva Global Medical Affairs, Petach Tikva, Israel

Nancy RicciottiTeva Branded Pharmaceutical Products, R&D, Inc., Frazer, PA, USA

show all

Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date